Inhibitory effects of propentofylline on [3H]adenosine influx. A study of three nucleoside transport systems.
The neuroprotective effects of adenosine are well-recognized. Recently, propentofylline, a xanthine derivative, has been shown to increase extracellular concentrations of adenosine in ischemic brain and to limit the extent of neuronal damage in experimental models of cerebral ischemia. Since the concentration of adenosine in brain is controlled, in part, by nucleoside transporter proteins, the action of propentofylline was proposed to be due to inhibition of mediated transfer of adenosine across cell membranes. To determine the likelihood of this mechanism, we examined the inhibitory effects of propentofylline on [3H]adenosine transport by the three best-characterized nucleoside transport processes, es, ei, and cif in cultured cell lines under conditions where only a single transporter type was operative. Propentofylline inhibited [3H]adenosine uptake by each of the three transport processes in a concentration-dependent manner. The greatest inhibitory potency was for es transporters (L1210/B23.1 cells), with an IC50 value of 9 microM, followed by ei transporters, with IC50 values of 170 microM (L1210/C2 cells) and 166 microM (Walker 256 cells). Propentofylline was a weak inhibitor of cif transporter, with an IC50 value of 6 mM. These results demonstrate that propentofylline is an inhibitor of adenosine transport processes and suggest that its neuroprotective effects may be due to an increase in extracellular concentrations of adenosine by virtue of inhibition of es transporter function.
Department of Biochemistry, University of Alberta, Edmonton, Canada.
F E
FE
Parkinson
A R
AR
Paterson
J D
JD
Young
C E
CE
Cass
D000241:Adenosine / Q000378:metabolism*; D000818:Animals; D001692:Biological Transport / Q000187:drug effects; D002545:Brain Ischemia / Q000378:metabolism; D002460:Cell Line; D051379:Mice; D051381:Rats; D013868:Thioinosine / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors / Q000494:pharmacology; D014316:Tritium; D014407:Tumor Cells, Cultured / Q000187:drug effects; D014970:Xanthines / Q000494:pharmacology*
D014970:Xanthines; D014316:Tritium; D013868:Thioinosine; C032114:propentofylline; C001789:4-nitrobenzylthioinosine; D000241:Adenosine